Shenzhen Mindray Bio-Medical Electronics revenue and financials
¥161.32Change from previous close: +1.45%Absolute change: +¥2.31
In the fiscal year ended December 2025, Shenzhen Mindray Bio-Medical Electronics reported revenue of ¥33.28B (−9.38% year over year). Net income was ¥8.14B, a net margin of 24.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −9.38%
- 2025 vs 2024
- Net income growth
- −30.28%
- 2025 vs 2024
- Net margin
- 24.4%
- 2024: 31.8%
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 59,267 | 56,644 | 47,940 | 46,745 | — |
| Current assets | 27,410 | 25,647 | 26,875 | 30,606 | — |
| Cash and equivalents | 17,690 | 16,644 | 18,787 | 23,186 | — |
| Short-term investments | 250 | — | — | — | — |
| Inventory | 5,004 | 4,757 | 3,979 | 4,025 | — |
| Net property, plant and equipment | 11,150 | 10,035 | 8,221 | 6,290 | — |
| Goodwill | 11,404 | 11,093 | 5,062 | 4,403 | — |
| Other intangible assets | 6,671 | 7,076 | 2,567 | 2,274 | — |
| Long-term investments | 180 | 197 | 66.6 | 60.8 | — |
| Current liabilities | 11,600 | 10,427 | 10,103 | 11,770 | — |
| Accounts payable | 3,242 | 2,793 | 2,690 | 2,291 | — |
| Long-term debt | 4.1 | 0.3 | 1.4 | — | — |
| Total debt | 349 | 298 | 295 | 237 | — |
| Total liabilities | 16,255 | 15,885 | 14,594 | 14,746 | — |
| Total equity (incl. minority) | 43,011 | 40,758 | 33,346 | 31,999 | — |
| Retained earnings | 30,143 | 27,621 | 24,680 | 23,761 | — |
| Minority interest | 4,918 | 4,902 | 261 | 18.3 | — |